Protecting effects of intravenous insoluble glycogen treatment on the experimental necrotizing acute pancreatitis of dogs.

Sipka, S; Sapy, P; Bot, G; Furka, I; Mikó, I; Arkossy, P; Dauda, G; Szappanos, M; Kovacs, J; Lakos, G; Szegedi, G

Sipka, S; Sapy, P; Bot, G; Furka, I; Mikó, I; Arkossy, P; Dauda, G; Szappanos, M; Kovacs, J; Lakos, G; Szegedi, G.

Affiliation

Sipka S; 3rd Department of Internal Medicine, University Medical School of Debrecen.

Hepatogastroenterology ; 44(13): 127-32, 1997.

Article in En | MEDLINE | ID: mdl-9058130

Subject(s)

Glycogen/therapeutic use; Pancreatitis, Acute Necrotizing/drug therapy; Amylases/blood; Animals; Dogs; Female; Glycogen/administration & dosage; Glycogen/metabolism; Injections, Intravenous; Lipase/blood; Male; Pancreatitis, Acute Necrotizing/enzymology; Phospholipases A/metabolism; Phospholipases A2; Solubility

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatitis, Acute Necrotizing / Glycogen Limits: Animals Language: En Journal: Hepatogastroenterology Year: 1997 Type: Article

Search on Google

XML

PubMed Links